Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for use as anti-infectives;
pharmaceutical preparations for the treatment of viral
conditions, namely human immunodeficiency virus (HIV), human
papilloma virus (HPV), respiratory syncytial virus (RSV),
hepatitis, herpes genitals, herpes labialis, herpes simplex
virus, varicella-zoster virus, Epstein-barr virus and
cytomegalovirus; pharmaceutical preparations for the
treatment and prevention of respiratory diseases and
disorders and their symptoms; pharmaceutical preparations
for the treatment of immune system related diseases and
disorders, namely immunosuppressants; pharmaceutical
preparations for the treatment of immunologic diseases and
disorders namely, autoimmune diseases and disorders;
pharmaceutical preparations for the treatment of
atherosclerosis; pharmaceutical preparations for the
treatment and prevention of metabolic related diseases and
disorders namely, disorders of the endocrine system, namely
growth and thyroid disorders, diabetes, metabolic syndrome,
obesity, weight loss and weight management; pharmaceutical
preparations for the treatment and prevention of
cardiovascular, cardiopulmonary, cardio-renal and renal
diseases and disorders; pharmaceutical preparations for the
prevention and treatment of oncological diseases and
disorders; pharmaceutical preparations for the treatment of
inflammation and inflammatory related diseases and disorders
namely arthritis, rheumatoid arthritis, inflammatory bowel
diseases, inflammatory connective tissue diseases,
vasculitis, synovitis; pharmaceutical preparations for the
prevention and treatment of sequelae of oncologic diseases
and their treatment namely nausea and vomiting, hematologic
depression, mucositis, cachexia, pain, bone pain and
fatigue; pharmaceutical preparations for the treatment of
blood-related diseases and disorders namely
thrombocytopenia, coagulation disorders, bleeding disorders,
platelet disorders, blood vessel disorders, sickle-cell
disease and its related disorders, anemias, sepsis and
infections in and of the blood; pharmaceutical preparations
for the treatment of musculoskeletal diseases, disorders and
injuries namely connective tissue diseases, bone diseases,
osteoporosis, spinal diseases, back pain, gout fractures,
sprains, osteogenesis imperfecta, muscle wasting (cachexia),
renal osteodystrophy, cartilage injuries, joint replacement
and osteoarthritis; pharmaceutical preparations for use in
ophthalmology; pharmaceutical preparations for the treatment
of dermatological diseases and disorders namely dermatitis,
skin and skin structure infections namely bacterial skin
infections, fungal skin infections, viral skin infections
and parasitic skin infections, psoriasis, eczema and
transmitted diseases; pharmaceutical preparations for the
treatment of hormonal related diseases and disorders namely
hypogonadism, testosterone disorders, androgen disorders and
estrogen disorders; pharmaceutical preparations for the
treatment of gastrointestinal related diseases and disorders
namely irritable bowel disorders and symptoms, digestive
disorders and acid-related disorders, namely acidifiers to
increase levels of gastric acid to decrease stomach pH for
human purposes; pharmaceutical preparations for the
treatment of sexual dysfunction namely erectile dysfunction,
male and female sexual dysfunction disorders namely arousal
disorder, pain disorder, desire disorder and orgasm
disorder; pharmaceutical preparations for the treatment of
genitourinary diseases namely urological diseases and
disorders namely amenorrhoea, dysmenorrhoeal and
infertility; pharmaceutical hormonal preparations namely
corticosteroids, hormone replacement therapy preparation,
oral contraceptives, thyroid hormone preparations;
pharmaceutical preparations for the treatment of
incontinence, prostate diseases and disorders, bladder
diseases and disorders; pharmaceutical preparations for the
treatment of sexually transmitted diseases, inflammatory
pelvic diseases, vasomotor symptoms, menopausal symptoms,
endometriosis, uterine fibroids, Leiomyoma, endourological
disorders and for the removal of renal calculi and the
treatment of nephrolithiasis and urolithiasis, pre-eclampsia
and pre-term labour; pharmaceutical preparations for the
treatment of prostatitis, nephritis, cystitis, vaginitis,
renal disease; pharmaceutical preparations for the treatment
of premenstrual dysphoric disorder, premenstrual syndrome,
male hypogonadism and hormonal disorders namely hepatitis,
non-alcoholic fatty liver disease (NAFLD), non-alcoholic
steatohepatitis (NASH), liver fibroids, and cirrhosis;
pharmaceutical preparations for the treatment of alopecia
and androgenic alopecia (male pattern baldness);
pharmaceutical preparations for the treatment of psychiatric
diseases and disorders namely mood disorders, anxiety
disorders, cognitive disorders, schizophrenia, and
psychoses; pharmaceutical preparations for the treatment of
damaged skin and tissue namely bee stings, sunburn, rashes,
sores, corns, calluses and acne; pharmaceutical preparations
for the treatment of inflammatory connective tissue diseases
and injuries; pharmaceutical preparations for the treatment
of malaria; pharmaceutical preparations for the treatment of
tuberculosis; allergy medication; vaccines for human use.
|
Goods & Services Limitation Details
|
Description
Class 05 -
Pharmaceutical preparations for use as anti-infectives;
pharmaceutical preparations for the treatment of viral
conditions, namely human immunodeficiency virus (hiv), human
papilloma virus, respiratory syncytial virus, hepatitis,
herpes genitals, herpes labialis, herpes simplex virus,
varicella-zoster virus, epstein-barr virus and
cytomegalovirus; pharmaceutical preparations for the
treatment and prevention of respiratory diseases and
disorders and their symptoms; pharmaceutical preparations
for the treatment of immune system related diseases and
disorders, namely immunosuppressants; pharmaceutical
preparations for the treatment of immunologic diseases and
disorders namely, autoimmune diseases and disorders;
pharmaceutical preparations for the treatment of
atherosclerosis; pharmaceutical preparations for the
treatment of viral conditions namely human immunodeficiency
virus (hiv), hpv, rsv, hepatitis, herpes genitalis, herpes
labialis, herpes simplex virus, varicella-zoster virus,
epstein barr virus and cytomegalovirus; pharmaceutical
preparations for the treatment and prevention of metaboic
related diseases and disorders namely, disorders of the
endocrine system, namely growth and thyroid disorders,
diabetes, metabolic syndrome, obesity, weight loss and
weight management; pharmaceutical preparations for the
treatment and prevention of cardiovascular, cardiopulmonary,
cardio- renal and renal diseases and disorders;
pharmaceutical preparations for the prevention and treatment
of oncological diseases and disorders; pharmaceutical
preparations for the treatment of inflammation and
inflammatory related diseases and disorders namely
arthritis, rheumatoid arthritis, inflammatory bowel
diseases, inflammatory connective tissue diseases,
vasculitis, synovitis; pharmaceutical preparations for the
prevention and treatment of sequelae of oncologic diseases
and their treatment namely nausea and vomiting, hematologic
depression, mucositis, cachexia, pain, bone pain and
fatigue; pharmaceutical preparations for the treatment of
blood-related diseases and disorders namely
thrombocytopenia, coagulation disorders, bleeding disorders,
platelet disorders, blood vessel disorders, sickle-cell
disease and its related disorders, anemias, sepsis and
infections in and of the blood; pharmaceutical preparations
for the treatment of musculoskeletal diseases, disorders and
injuries namely connective tissue diseases, bone diseases,
osteoporosis, spinal diseases, back pain, gout fractures,
sprains, sports injuries, osteogenesis imperfecta, muscle
wasting (cachexia), renal osteodystrophy, cartilage
injuries, joint replacement and osteoarthritis;
pharmaceutical preparations for use in ophthalmology;
pharmaceutical preparations for the treatment of
dermatological diseases and disorders namely dermatitis,
skin and skin structure infections namely bacterial skin
infections, fungal skin infections, viral skin infections
and parasitic skin infections, psoriasis, eczema and
transmitted diseases; pharmaceutical preparations for the
treatment of hormonal related diseases and disorders namely
hypogonadism, testosterone/androgen disorders and oestrogen
disorders; pharmaceutical preparations for the treatment of
gastrointestinal related diseases and disorders namely
irritable bowel disorders and symptoms, digestive disorders
and acid-related disorders; pharmaceutical preparations for
the treatment of sexual dysfunction namely erectile
dysfunction, male and female sexual dysfunction disorders
namely arousal disorder, pain disorder, desire disorder and
orgasm disorder; pharmaceutical preparations for the
treatment of genitourinary diseases namely urological
diseases and disorders namely amenorrhoea, dysmenorrhoeal
and infertility; pharmaceutical hormonal preparations namely
corticosteroids, hormone replacement therapy preparation,
oral contraceptives, thyroid hormone preparations;
pharmaceutical preparations for the treatment of
incontinence, prostate diseases and disorders, bladder
diseases and disorders; pharmaceutical preparations for the
treatment of sexually transmitted diseases, inflammatory
pelvic diseases, vasomotor/menopausal symptoms,
endometriosis/uterine fibroids, leiomyoma,
endourology/stone, pre-eclampsia and pre-term labour;
pharmaceutical preparations for the treatment of
prostatitis, nephritis, cystitis, vaginitis, renal disease;
pharmaceutical preparations for the treatment of
premenstrual dysphoric disorder, premenstrual syndrome, male
hypogonadism and hormonal disorders namely hepatitis,
non-alcoholic fatty liver disease (nafld), non-alcoholic
steatohepatitis (nash), liver fibroids, and cirrhosis;
pharmaceutical preparations for the treatment of alopecia
and androgenic alopecia (male pattern baldness);
pharmaceutical preparations for the treatment of psychiatric
diseases and disorders namely mood disorders, anxiety
disorders, cognitive disorders, schizophrenia, and
psychoses; pharmaceutical preparations for the treatment of
damaged skin and tissue namely bee stings, sunburn, rashes,
sores, corns, calluses and acne; pharmaceutical preparations
for the treatment of inflammatory connective tissue diseases
and injuries; pharmaceutical preparations for the treatment
of malaria; pharmaceutical preparations for the treatment of
tuberculosis; allergy medication; vaccines.
Class 05 -
Pharmaceutical preparations and substances for the treatment
of damaged skin and tissue; pharmaceutical preparations and
substances for the treatment of infectious diseases, blood
disorders, pain, inflammation, sepsis, alopecia, obesity and
cognitive disorders; pharmaceutical preparations and
substances for the treatment of viral, metabolic, endocrine,
musculoskeletal, cardiovascular, cardiopulmonary,
genitourinary, sexual dysfunction, oncological,
hepatological, ophthalmic, respiratory, neurological,
gastrointestinal, hormonal, dermatological, psychiatric and
immune systems related diseases and disorders; vaccines.
|